Therigy Poster Presentation WINS 1ST PLACE! NASP 2018

Therigy wins first place in Poster Presentation at NASP 2018

October 4, 2018

Our Therigy team just returned from the NASP (National Association of Specialty Pharmacies) Annual Meeting in Washington...

TherigySTM's New Integration with CareTend

Tuesday, August 28,2018, Therigy and Mediware hosted a webinar on our new integration coming soon.  If you are a current CPR+ and CareTend customer, contact us for a sneak peek into this new...

Therigy® Announces Free Webinar on Leveraging Technology for Patient Engage...

Therigy is pleased to announce a free webinar on the influence and leverage of technology for specialty patient engagement, Tuesday, April 24, 1-2pm EDT. 

Interested in learning the most effective...

ASHP 2017 Round Up: Research, Leadership, and Wine

Another American Society of Health-System Pharmacists (ASHP) Midyear Clinical Meeting & Exhibition has passed. At ASHP 2017, brilliant pharmacy leaders from around the country united in Orlando,...

Therigy® Announces Free Webinar to Assist Specialty Pharmacies in Deliverin...

Differentiation through quantifiable patient outcomes is specialty pharmacy’s new frontier. Specialty therapy management company Therigy will host a webinar to explore current trends and provide...

Therigy Updates Brand: Emphasizes Future of Therapy Outcomes

Focuses on Building, Elevating, and Proving Specialty Pharmacy Value

Therigy®, the company that pioneered patient-focused specialty therapy management in 2006, is making a subtle, yet powerful...

U.S. House Passes Landmark Legislation for Medicare Home Infusion Reimburse...

In July, the U.S. House of Representatives made strides in improving Medicare programs by passing H.R. 3178, the Medicare Part B Improvement Act of 2017. This legislation consists of three titles...

A Call for Transparency: NASP Pushes Back on DIR Fees and PBM Collusion

This month, the National Association of Specialty Pharmacy (NASP) has made its position clear on two controversial issues involving specialty drug pricing. The organization argues that a lack of...

Poll Results and Event Recap: URAC Specialty Pharmacy v3.0 Accreditation: L...

On Tuesday, July 11, over 350 professionals from specialty pharmacies and surrounding industries converged virtually for a webinar to help them better understand how to apply the changes that were...

Learn Insider Tips: Don’t Miss Therigy and Cleveland Clinic’s Webinar on UR...

In three weeks, Therigy and Cleveland Clinic will host a live webinar titled Preparing for URAC Specialty Pharmacy Accreditation v3.0: Learn Insider Tips to Satisfy the Latest Patient Management...

Therigy Congratulates Patient Choice Award Winners Announced at Specialty P...

Zitter Health Insights (ZHI) and Specialty Pharmacy Times presented the inaugural Patient Choice Awards at the 2017 Patient Choice Awards luncheon on May 2. The winners in the ceremony’s two...

Therigy Software Management of Over 300,000 Specialty Pharmacy Patients Ena...

TherigySTM provides powerful insights for evaluating and improving value-based patient outcomes across 21 therapeutic categories and associated drug therapies.

Maitland, FL — In an industry that’s...

A Year in Specialty Pharmacy: A Look Back at 2016's Top 5 Developments

2016 was an eventful year for specialty pharmacy and its providers. The industry continues to boom as more pharmaceutical companies and health systems see growing value in the market. In fact, Drug...

Therigy, LLC, Congratulates Publix Specialty Pharmacy on its URAC accredita...

On Dec. 19, 2016, the Utilization Review Accreditation Commission (URAC), the independent leader in promoting health care quality through accreditation, education, and measurement, announced the...

Therigy Invests in a Higher Level of Data Management Expertise

Brian Roberts Joins Therigy as Director of Data Analytics

Maitland, FL— Specialty pharmacy industry customers need technology solutions that fill knowledge gaps and resolve their business...

  Partner with Therigy to conduct outcomes studies based on real-world evidence across 20+ specialty disease states and 400+ specialty medications.
Learn More